An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN™ in Subjects With Cancer Who Also Have Impaired Renal Function
This study is currently recruiting participants.
Verified February 2013 by Eisai Inc.
Information provided by (Responsible Party):
First received: August 1, 2011
Last updated: February 19, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||August 2013 (Final data collection date for primary outcome measure)|